The first-in-class
Chimeric Adapter Proteins (CAP-T™) Cells for treatment of solid tumors
Redefining Cell Therapy
We are pushing the boundaries of cell-based cancer therapies with our innovative CAP-T™ technology. Our commitment is to elevate the standards of oncological treatments, targeting enhanced efficacy for solid tumors.
Our Technology
We have generated compelling in vivo and in vitro evidence underscoring the transformative potential of our CAP-T™ Technology. Explore the data that propels our transformative stride in cell-based cancer treatments.
Our Science
CAP-T™ signaling utilizes a specific intracellular mechanism distinct from traditional pathways. Explore the technical details and applications of our CAP-T™ Technology